carbostyril has been researched along with Adenoma, Prostatic in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Cui, X; Deng, Z; Han, B; Jiang, C; Jing, Y; Li, W; Shi, F; Sun, M; Xia, S; Xu, Z; Zhang, W; Zhou, Z | 1 |
Doi, T; Hashimoto, T; Iwata, M; Nagabukuro, H | 1 |
Costa, FJ | 1 |
Hatakeyama, T; Morita, M; Suzuki, K | 1 |
Fillastre, JP; Grise, P; Humbert, G; Leroy, A | 1 |
1 trial(s) available for carbostyril and Adenoma, Prostatic
Article | Year |
---|---|
Lomefloxacin prophylaxis in visual laser ablation of the prostate.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Bacteriuria; Fluoroquinolones; Humans; Laser Therapy; Male; Middle Aged; Postoperative Complications; Premedication; Prostate; Prostatic Hyperplasia; Quinolones | 1994 |
4 other study(ies) available for carbostyril and Adenoma, Prostatic
Article | Year |
---|---|
Rebamipide-loaded chitosan nanoparticles accelerate prostatic wound healing by inhibiting M1 macrophage-mediated inflammation via the NF-κB signaling pathway.
Topics: Alanine; Animals; Cell Proliferation; Chitosan; Dogs; Drug Compounding; Humans; Macrophages; Male; Nanoparticles; NF-kappa B; Prostate; Prostatic Hyperplasia; Quinolones; Wound Healing | 2020 |
Effects of TAK-802, a novel acetylcholinesterase inhibitor, and tamsulosin, an alpha1-adrenoceptor antagonist, and their synergistic effects on the urodynamic characteristics in a guinea-pig model of functional bladder outlet obstruction.
Topics: Acetylcholinesterase; Adrenergic alpha-Antagonists; Adrenergic beta-1 Receptor Antagonists; Animals; Cholinesterase Inhibitors; Drug Synergism; Drug Therapy, Combination; Guinea Pigs; Infusions, Intravenous; Male; Prostatic Hyperplasia; Pyrroles; Quinolones; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction; Urinary Retention; Urodynamics | 2005 |
[Lomefloxacin concentration in human prostatic tissue following 3-day administration].
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Infective Agents; Fluoroquinolones; Humans; Male; Middle Aged; Premedication; Prostate; Prostatectomy; Prostatic Hyperplasia; Quinolones | 1993 |
Penetration of lomefloxacin into human prostatic tissue.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Infective Agents; Fluoroquinolones; Humans; Male; Middle Aged; Premedication; Prostate; Prostatectomy; Prostatic Hyperplasia; Quinolones | 1992 |